PATENT CLAIM ANALYSIS

Application Number: 15746404
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-11
Patent Classification: ["435", "007100"]

Abstract:
The disclosure relates generally to methods of detecting and quantifying methotrexate (MTX) in a sample. The methods disclosed herein decrease cross-reactivity and improve sensitivity of the detection.

Claim (Index 24):
The method of  claim 2 , wherein the labeled MTX comprises at least one label selected from the group consisting of electrochemiluminescent labels or compounds, chemiluminescent compounds, enzyme labels, fluorophores, chromogenic compounds, radiolabels, catalysts, colorimetric, labeled antibodies, a latex particle, a magnetic particle, a paramagnetic particle, a radioactive element, fluorescent dyes, phosphorescent dyes, dye crystals, gold particles, silver colloidal particles, selenium colloidal particles, metal chelates, coenzymes, electro active groups, oligonucleotides and stable radicals.

Metadata:
- Claim Count in Document: 29.0
- Percentile: 86.0
- Lexical Diversity: 1.19231
- Patent Class: 435.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['12873926', '10280716', '14361731', '13836229', '14843285']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6158388234177266
- 35 USC 102 Novelty (BERT): 0.5122990887339086
- Combined Prediction Score: 0.6054848499493448
- Mean Citation Score: 253.792926
- Max Citation Score: 284.93808
- Similarity Product: 178.6726599307537

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test